MIRM

MIRM Stock-Based Compensation

$140.13MTTM · USD

Period ending:

MIRM FY Stock-Based CompUSD
MIRM FY Stock-Based Comp2018-12-31: $51.00K2019-12-31: $6.07M2020-12-31: $12.55M2021-12-31: $23.09M2022-12-31: $27.01M2023-12-31: $35.02M2024-12-31: $48.44M2025-12-31: $71.42M$71.42M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

MIRM stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Mirum Pharmaceuticals Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
71,424,000
48,444,000
35,023,000
27,007,000
23,087,000
12,554,000
6,070,000
51,000

Compare stock-based compensation

All MIRM financial metrics · MIRM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.